Navigation Links
GOCE's 'heart' starts beating
Date:4/8/2009

GOCE's highly sensitive gradiometer instrument has been switched on and is producing data. Forming the heart of GOCE, the gradiometer is specifically designed to measure Earth's gravity field with unprecedented accuracy.

"We are very pleased with what we have seen from the gradiometer from the moment it was switched on. All accelerometer sensor heads are working in very good health and provide meaningful data," GOCE Project Manager Danilo Muzi said.

The gradiometer consists of three pairs of identical ultra-sensitive accelerometers, each mounted to point in orthogonal directions to allow the simultaneous measurement of the spatial variations of the gravity field.

With the switching on of the gradiometer, all systems on the satellite have now been activated. The satellite's sophisticated electric ion propulsion system was switched on last week and continues to operate normally.

In order to get the maximum performance from the gradiometer, GOCE was designed to provide a highly stable and undisturbed environment. However, GOCE has to orbit Earth close enough to measure the tiny differences in gravity, which forces it to endure significant drag from the uppermost layers of the atmosphere.

The atmospheric drag is compensated for by the ion engine, which is able to deliver between 1 and 20 milliNewtons of thrust (the force equivalent to our exhaling).

GOCE was injected into orbit at an altitude of 283 km on 17 March. Since then, it has been freefalling at a rate of 150 to 200 m a day and will continue to do so until it enters 'drag-free mode' at an altitude of 273 km.

At this altitude, the satellite will actively compensate for the effect of air drag and its payload will undergo a further six weeks of commissioning and calibration. Mission operations are scheduled to start in summer 2009.

"With the ion engine and the gradiometer working, we have started to tune the satellite and its instruments," GOCE System Manager Michael Fehringer said.

"We have a lot of work ahead of us, but it is a highly exciting time for everyone involved in the mission," GOCE Mission Manager Rune Floberghagen added.

Data from GOCE will be used to create an extremely accurate map of Earth's gravity field. Together with altimetry data from missions, such as ESA's Envisat, the GOCE gravity map will allow scientists to measure sea-surface height more accurately and understand sea-level change and ocean circulation better.


'/>"/>

Contact: Robert Meisner
robert.meisner@esa.int
39-069-418-0874
European Space Agency
Source:Eurekalert

Related medicine news :

1. Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
2. Exercise is safe, improves quality of life in patients with chronic heart failure
3. Heart Transplant Failures More Likely in Poor, Minority Kids
4. Obesity Linked to Heart Failure Risk
5. Exercise Might Benefit Some With Heart Failure
6. American Heart Association Statement Gives Guidance on Minimally Invasive Procedures to Treat Diseased Brain Vessels
7. Link between widely used osteoporosis drugs and heart problems probed
8. Heart Failure Congress 2009
9. Interleukin Genetics Grants LABEC Pharma a License for Sales and Distribution of Its Heart Health Genetic Test
10. Berlin Heart Receives First Regulatory Approval in North America
11. American Heart Association Leads Efforts to Reduce Preventable Deaths and Rehospitalizations for Heart Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” Pate ... year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children ... those children. James saw firsthand the effect of the critical funding gap for research ...
(Date:1/19/2017)... ... January 19, 2017 , ... Connecticut Dermatology Group (CDG) ... a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background in ... “It is with considerable pleasure to welcome back Dr. Kim to the CDG team” ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... From a ... are released almost daily linking gut health to chronic disease, mental health and general ... Year ” as an important resolution to consider. , For one Charlottesville restaurant, good ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced ... to compete in the Boston Marathon on April 17. From first-time participants to ... marathon to join Team V and support the Foundation’s mission to declare victory over ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)...   Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to restore ... the Company,s operating results for 2016 and an outline ... Company described in its recent 10-K filing with the ... The Company,s contract laboratory completed its evaluation of NovaDerm®, ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: